Leadership Overview
Cold Spring Harbor Laboratory has 4 executives leading key functions including operations, sponsored programs, advancement, and organizational strategy.
Dedicated to advancing biomedical discovery, Cold Spring Harbor Laboratory fosters a collaborative environment where researchers explore cancer, neuroscience, and plant biology to improve global health outcomes.
Dedicated to advancing biomedical discovery, Cold Spring Harbor Laboratory fosters a collaborative environment where researchers explore cancer, neuroscience, and plant biology to improve global health outcomes.
Leadership Roles at Cold Spring Harbor Laboratory
John Tuke - Chief Operating Officer
John Tuke, the Chief Operating Officer at Cold Spring Harbor Laboratory, directs all internal infrastructure and administrative functions. Overseeing the daily operations of this non-profit biomedical research facility, the Chief Operating Officer ensures that laboratory resources align with scientific objectives. This leadership role involves managing complex facility requirements and optimizing support systems for cancer and neuroscience research teams. By streamlining administrative workflows, John Tuke directly impacts the efficiency of the entire research enterprise. Tuke maintains rigorous standards across all campus operations, facilitating a productive environment for scientists. Through the coordination of support departments, the Chief Operating Officer secures the operational stability necessary for long-term breakthroughs in quantitative biology. Tuke manages the logistical framework that allows researchers to focus exclusively on high-impact scientific discovery, ensuring that the laboratory remains at the forefront of global biomedical innovation.

Charles Prizzi - Senior VP, Advancement & Special To The Advisor & President
Charles Prizzi, the Senior VP, Advancement & Special To The Advisor & President at Cold Spring Harbor Laboratory, directs all philanthropic initiatives and strategic partnerships. Overseeing the development of long-term donor relationships, the Senior VP, Advancement & Special To The Advisor & President ensures that the laboratory maintains the financial support required for its biomedical research mission. This leadership role involves crafting communication strategies that highlight the impact of cancer and neuroscience research to potential benefactors. By expanding the donor base, Charles Prizzi directly impacts the growth of the institution's research capabilities. Prizzi collaborates with the President to align advancement efforts with the broader vision of the laboratory. Through the cultivation of strategic alliances, the Senior VP, Advancement & Special To The Advisor & President secures the resources needed for future scientific endeavors. Prizzi drives the laboratory's public engagement, ensuring that the institution's contributions to plant biology and quantitative biology receive widespread recognition.
Morgan Browne - President
Morgan Browne, the President at Cold Spring Harbor Laboratory, directs the overall strategic vision and scientific mission of the institution. Overseeing the integration of cancer, neuroscience, and plant biology research, the President ensures that the laboratory remains a global leader in biomedical discovery. This leadership role involves setting institutional priorities and fostering a culture of innovation among the research faculty. By guiding the long-term development of the laboratory, Morgan Browne directly impacts the trajectory of modern biological science. Browne coordinates with the Board and executive leadership to maintain the institution's reputation for excellence. Through the implementation of high-level research policies, the President secures the laboratory's position at the forefront of quantitative biology. Browne manages the overarching strategy that connects scientific inquiry with educational outreach, ensuring that the laboratory continues to produce transformative knowledge that addresses critical health challenges on a global scale.
Walter Goldschmidts - Vice President and Executive Director, Office of Sponsored Programs
Walter Goldschmidts, the Vice President and Executive Director, Office of Sponsored Programs at Cold Spring Harbor Laboratory, manages the acquisition and compliance of external research funding. Overseeing the financial lifecycle of grants, the Vice President and Executive Director, Office of Sponsored Programs ensures that all research initiatives meet regulatory requirements and sponsor expectations. This leadership role involves navigating complex funding landscapes to support cancer, neuroscience, and plant biology projects. By optimizing the grant application process, Walter Goldschmidts directly impacts the laboratory's ability to sustain cutting-edge research. Goldschmidts coordinates with principal investigators to align project goals with available financial resources. Through the management of sponsored programs, the Vice President and Executive Director, Office of Sponsored Programs secures the necessary capital for ongoing scientific exploration. Goldschmidts maintains institutional integrity by overseeing rigorous reporting standards, ensuring that all research activities remain fully compliant with federal and private funding mandates.
Explore Leadership Teams in Business Services
PAREXEL International Corporation, a biopharmaceutical outsourcing services company, provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting Services (PC), and PAREXEL Informatics (PI). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management, and biostatistical analysis, epidemiology and health economics/outcomes research, clinical supply and drug logistics, pharmacovigilance, commercialization, and clinical pharmacology, as well as related medical affairs, patient recruitment, and investigator site services. The PC segment provides technical expertise and advice in various areas, such as drug development, regulatory affairs, product pricing and reimbursement, commercialization, and strategic compliance; and market and product development, and targeted communications services to support product launch, as well as offers solutions to address client issues associated with product development, registration, and commercialization. The PI segment provides information technology solutions comprising ClinPhone randomization and trial supply management solutions, medical imaging services, IMPACT clinical trial management systems, LIQUENT InSight regulatory information management software and professional services, DataLabs electronic data capture systems, Web-based portals, systems integration services, electronic patient reported outcomes, and patient diary applications, as well as centralized assessment services for patient technology solutions. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham,...
Company Leadership FB


AS
Charles River has delivered solutions to accelerate the development of drugs, chemicals, and medical devices for the people and patients who need them. Our products and services support clients from basic research, discovery, and safety assessment, to manufacturing and commercialization. With this expansive end-to-end portfolio, global capacity, and proven scientific and regulatory advisors, our integrated approach enables maximum speed and confidence on the drive to market.
Company Leadership
AC

MH
Founded in 1969, Bionetics Corporation is a company that offers environmental monitoring, readiness monitoring, and instrument calibration services. They are based in Yorktown, Virginia.
Company Leadership DT
HR
CH
KV
The Emmes Group is a global research and consulting organization specializing in scientific and clinical research, data management, and program evaluation. The company provides comprehensive services in the areas of public health, biomedical research, and life sciences, partnering with government agencies, non-profit organizations, and private sector clients. With expertise in research design, data analysis, and management consulting, The Emmes Group is dedicated to advancing evidence-based solutions that improve health outcomes and drive innovation in scientific research.
Company Leadership
JR
KM
